Terminology Service < Semantic Lookup Platform

All terms in EFO

Label	Id	Description
obsolete_congenital enteropathy involving intestinal mucosa development	Orphanet_104007
Congenital intestinal disease due to an enzymatic defect	Orphanet_104006
obsolete_intestinal disease due to vitamin absorption anomaly	Orphanet_104004
obsolete_congenital intestinal transport defect	Orphanet_104003
mesenchymal stem cell	EFO_0000586
obsolete_polyglucosan body myopathy	Orphanet_397937
mesothelial neoplasm	EFO_1001044	[A benign or malignant neoplasm arising from mesothelial cells. Mesothelial cells are the lining cells of the pleura and peritoneum. -- 2003]
Lycopersicon	NCBITaxon_49274
quercetin	CHEBI_16243	[A pentahydroxyflavone having the five hydroxy groups placed at the 3-, 3'-, 4'-, 5- and 7-positions., A pentahydroxyflavone that has formula C15H10O7.]
hydrogen peroxide	CHEBI_16240	[An inorganic peroxide that has formula H2O2.]
spike-in quality control role	OBI_0001140	[a reference substance role that is borne by a material entity with a known amount which is mixed into the evaluant of assays for quality control or data normalization purposes, A reference substance role that is borne by a material entity with a known amount which is mixed into the evaluant of assays for quality control or data normalization purposes.]
dye swap quality control role	OBI_0001142	[A reference substance role that is borne by a material entity used in a dye swap design experiment for quality control or data normalization purposes, a reference substance role that is borne by a material entity used in a dye swap design experiment for quality control or data normalization purposes]
rotenone	CHEBI_28201	[A chromenone that has formula C23H22O6.]
ethanol	CHEBI_16236	[A member of the ethanols that has formula C2H6O., An ethanol that has formula C2H6O., A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in alcoholic beverages. (PubChem) Pharmacology: Alcohol produces injury to cells by dehydration and precipitation of the cytoplasm or protoplasm. This accounts for its bacteriocidal and antifungal action. When alcohol is injected in close proximity to nerve tissues, it produces neuritis and nerve degeneration (neurolysis). Ninety to 98% of ethanol that enters the body is completely oxidized. Ethanol is also used as a cosolvent to dissolve many insoluble drugs and to serve as a mild sedative in some medicinal formulations. Mechanism of action: The sedative effects of ethanol are mediated through binding to GABA receptors and glycine receptors (alpha 1 and alpha 2 subunits). In its role as an anti-infective, ethanol acts as an osmolyte or dehydrating agent that disrupts the osmotic balance across cell membranes. Drug type: Approved. Small Molecule. Drug category: Anti-Infective Agents, Local. Central Nervous System Depressants. Disinfectants. Solvents]
obsolete_combined immunodeficiency due to MALT1 deficiency	Orphanet_397964
Liriodendron tulipifera	NCBITaxon_3415
pregnancy associated osteoporosis	MONDO_0100194	[A severe early presentation of osteoporosis in which young women experience low trauma or spontaneous fractures, most commonly vertebral fractures, during late pregnancy or lactation.]
X-linked intellectual disability with hypopituitarism	MONDO_0100195	[An X-linked intellectual disability in which the cause of the disease is a mutation in the SOX3 gene, with variable phenotypes including growth hormone deficiency due to hypopituitarism. It is undetermined if SOX3 is the only gene associated with this disease.]
hypopituitarism	EFO_0001380	[A condition of diminution or cessation of secretion of one or more hormones from the anterior pituitary gland. This may result from surgical or radiation ablation, non-secretory pituitary neoplasms, metastatic tumors, infarction, pituitary apoplexy, infiltrative or granulomatous processes, and other conditions., Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions.]
obsolete_Charcot-Marie-Tooth disease type 2R	Orphanet_397968